The development of medical diagnostic tests is of great importance in clinical practice, public health, and medical research. The receiver operating characteristic (ROC) curve is a popular tool for evaluating the accuracy of such tests. We review Bayesian nonparametric methods based on Dirichlet process mixtures and the Bayesian bootstrap for ROC curve estimation and regression. The methods are illustrated by means of data concerning diagnosis of lung cancer in women.
Introduction
Medical diagnostic tests are designed to discriminate between alternative states of health, generally referred throughout as diseased and non-diseased/healthy states. Their ability to discriminate between these two states must be rigorously assessed trough statistical analysis before the test is approved for use in practice. In what follows, we assume the existence of a gold standard test, that is, a test that perfectly classifies the individuals as diseased and non-diseased. Compared to the truth one wants to know how well the test being evaluated performs.
The accuracy of a dichotomous test, a test that yields binary results (e.g., positive or negative), can be summarized by its sensitivity and specificity. The sensitivity (Se) is the test-specific probability of correctly detecting diseased subjects, while the specificity (Sp) is the test-specific probability of correctly detecting healthy subjects. In turn, the accuracy of a continuous scale diagnostic test is measured by the separation of test outcomes distribution in the diseased and non-diseased populations.
The receiver operating characteristic (ROC) curve, which is a plot of Se against 1 − Sp for all cutoff points that can be used to convert continuous test outcomes into dichotomous outcomes, measures exactly such amount of separation and it is probably the most widely used tool to evaluate the accuracy of continuous or ordinal tests.
A critical aspect when developing inference for ROC curves is the specification of a probability distribution for the test outcomes in the diseased and healthy groups. The main issue is that parametric models, such as the binormal model (arising when a normal distribution is assumed for both populations), are often too restrictive to capture nonstandard features of the data, such as skewness and multimodality, potentially leading to unsatisfactory inferences on the ROC curve. In these situations, we would like to relax parametric assumptions in order to gain modeling flexibility and robustness against misspecification of a parametric statistical model. Specifically, we would like to consider flexible modeling approaches that can handle nonstandard features of the data when that is needed, but that do not overfit the data when parametric assumptions are valid.
Moreover, recently, the interest on the subject has moved beyond determining the basic accuracy of a test. It has been recognized that the discriminatory power of a test is often affected by patient-specific characteristics, such as age or gender. In this situations, the parameter of interest is a collection of ROC curves associated with different covariate levels. In this context, understanding the covariate impact on the ROC curve may provide useful information regarding the test accuracy toward different populations or conditions. On the other hand, ignoring the covariate effects may lead to biased inferences about the test accuracy. As in the no-covariate case, here it is also important to consider flexible modeling approaches for assessing the effect of the covariates on test accuracy and, consequently, on the corresponding ROC curves.
In this chapter, we discuss two Bayesian nonparametric (BNP) approaches that are used to obtain data-driven inferences for a single ROC curve, based on mixtures induced by a Dirichlet process (DP) and on the Bayesian bootstrap. We also discuss an approach to model covariate-dependent ROC curves based on mixture models induced by a dependent DP (DDP), which allows for the entire distribution of the test outcomes, in each population, to smoothly change as a function of covariates. The chapter is organized as follows. In Sect. 16.2 we provide background material on ROC curves. BNP approaches for single ROC curve estimation are discussed in Sect. 16.3. A BNP ROC regression model is discussed in Sect. 16.4. In Sect. 16.5 we illustrate the methods using data concerning diagnosis of lung cancer in women. We conclude with a short discussion in Sect. 16.6.
ROC Curves
Let Y 0 and Y 1 be two independent random variables denoting the diagnostic test outcomes in the non-diseased and diseased populations, with cumulative distribution function (CDF) F 0 and F 1 , respectively. Further, let c be a cutoff value for defining a positive test result and, without loss of generality, we proceed with the assumption that a subject is classified as diseased when the test outcome is greater or equal than c and as non-diseased when it is below c. Then, for each cutoff value c, the sensitivity and specificity associated with such decision criterion are
Obviously, for each value of c, we obtain a different sensitivity and specificity. The ROC curve summarizes the tradeoffs between Se and 1 − Sp (also known as false positive fraction) as the cutoff c is varied and it corresponds to the set of points
Alternatively, and letting p = 1 − F 0 (c), the ROC curve can be expressed as
where
ROC curves measure the amount of separation between the distribution of the test outcomes in the diseased and nondiseased populations. Figure 16 .1 illustrates the effect of separation on the resulting ROC curve. When both distributions completely overlap, the ROC curve is the diagonal line of the unit square (that is, Se(c) = 1 − Sp(c) for all c), thus indicating an useless test. On the other hand, the more separated the distributions the closer the ROC curve is to the point (0, 1) in the unit square. A curve that reaches the point (0, 1) has Sp(c) = Se(c) = 1 for some cutoff c, and hence corresponds to a perfect test. As it is clear from expression (16.1), estimating the ROC curve is basically a matter of estimating the distribution functions of the diseased and non-diseased populations and, hence, flexible models for estimating such distributions are in order.
Related to the ROC curve is the notion of placement value (Pepe and Cai 2004) , which is simply a standardization of test outcomes with respect to a reference population. Let U = 1 − F 0 (Y 1 ) be the placement value of diseased subjects with respect to the non-diseased population. This variable quantifies the degree of separation between the two populations. Specifically, if the test outcomes in the two populations are highly separated, the placement of most diseased individuals is at the upper tail of the non-diseased distribution, so that most diseased individuals will have small placement values. In turn, if the populations overlap substantially, U will have a Uniform(0, 1) distribution. Interestingly, the ROC curve turns out to be the CDF of U
It is common to summarize the information of the ROC curve into a single summary index and the most widely used is the area under the ROC curve (AUC), which is defined as AUC = 1 0 ROC(p)dp. The AUC can be interpreted as the probability that an individual chosen from the diseased population exhibits a test outcome greater than the one exhibited by a randomly selected individual from the non-diseased population, that is, AUC = Pr(Y 1 > Y 0 ). A test with a perfect discriminatory ability would have AUC = 1, while a test with no discriminatory power would have AUC = 0.5. Although there are some other summary indices available, such as the Youden index (Fluss et al. 2005) , which has the nice feature of providing an optimal cutoff for screening subjects in practice, or the partial AUC (Dodd and Pepe 2003) , which is a meaningful measure for cases where only a specific region of the ROC curve (e.g., high sensitivities or specificities) is of clinical interest, throughout this chapter we use the AUC as the preferred summary measure of diagnostic accuracy. Now, suppose that along with Y 0 and Y 1 , covariate vectors x 0 and x 1 are also available. Hereafter, we assume that these covariates are the same in both populations. However, this not always have to be the case. For instance, the severity of disease could play an important role on the discriminatory power of the test. As a natural extension of the ROC curve, the conditional or covariate-dependent ROC curve, for a given covariate level x, is defined as There is a vast literature on parametric, semiparametric, and nonparametric frequentist ROC data analysis. The books by Pepe (2003) and Zhou et al. (2011) discuss many frequentist approaches to ROC curve estimation and regression. See also the recent surveys by Gonçalves et al. (2014) and Pardo-Fernández et al. (2014) . The amount of existing work in the Bayesian literature is by comparison reduced. This is particularly valid for the BNP literature, which is fairly limited. Recent work on the latter includes the DP mixture (DPM) model-based approach of Erkanli et al. (2006) , the Bayesian bootstrap ROC curve estimator of Gu et al. (2008) , and the stochastic ordering approach of Hanson et al. (2008a) . Moreover, Branscum et al. (2008) used mixtures of finite Polya trees to analyze ROC data when the true disease status is unknown (that is, when there is no gold standard), while Hanson et al. (2008b) used bivariate mixtures of finite Polya trees to model data from two continuous tests. Additionally, Inácio et al. (2011) proposed the use of mixtures of finite Polya trees to model the ROC surface for problems where the patients have to be classified into one of three ordered classes. In what respects ROC regression, Inácio de Carvalho et al. (2013) proposed to model the conditional ROC curve using DDPs, whereas Rodríguez and Martínez (2014) used Gaussian process priors to model the mean and variance functions in each population and then computed the corresponding induced ROC curve. Finally, Branscum et al. (2014) proposed a method based on mixtures of finite Polya trees to model ROC regression data when there is not a gold standard test available.
Modeling Approaches for the No Covariate Case

DPM Models
When seeking for flexible modeling approaches and inferences for the distributions of the test outcomes in each population, mixture models appear as a natural option. More specifically, mixtures of normal distributions are particularly well suited for our purposes. Let (Y 01 , . . . ,Y 0n 0 ) and (Y 11 ,...,Y 1n 1 ) be random samples of sizes n 0 and n 1 from the non-diseased and diseased populations, respectively. It would be natural to assume that
where Φ(· | μ, σ 2 ) denotes the CDF of the normal distribution with mean μ and variance σ 2 . Thus, each test outcome would arise from one of the K h mixture components, with each component having its own mean and variance. The model in (16.5) can be equivalently written as
where G h is a discrete mixing distribution given by
with δ a (·) denoting the Dirac measure at a. Usually, the weights {ω hk } are assigned a Dirichlet distribution, while the component specific parameters {(μ hk , σ 2 hk )} arise from a prior distribution, say, G 0h (μ h , σ 2 h ), typically, a normal-inverse-gamma distribution. Hence, placing a prior on the collection
is equivalent to placing a prior on the discrete mixture distribution G h . A drawback of this model specification is that we must choose the number of components K h , which is not a trivial task in general. Although there are methods available that place an explicit parametric prior on K h , they tend to be quite difficult to implement efficiently. An alternative is to use a DP prior (Ferguson 1973 (Ferguson , 1974 for G h , which, on one hand, offers the theoretical advantage of having full weak support on all mixing distributions and, on the other hand, the practical advantage of automatically determining the number of components that best fits a given dataset. We write G h ∼ DP(α h , G 0h ) to denote that a DP prior is being assumed for G h , which is defined in terms of a parametric centering distribution G 0h (for which E(G h ) = G 0h ), and a precision parameter α h (α h > 0) which controls the uncertainty of G h about G 0h .
Undoubtedly, the most useful definition of the DP is its constructive definition (Sethuraman 1994) , according to which G h has an almost sure representation of the form 6) where (μ hk , σ 2 hk )
iid ∼ G 0h and the weights arise from a stick breaking construction
The resulting model for the test outcomes in each population is then a DPM of normals and is written as
where the centering distribution G 0h is defined on IR × IR + . More specifically, we take G 0h to be the normal-inverse-gamma distribution, that is,
where N(μ, σ 2 ) is the normal distribution with mean μ and variance σ 2 and IG(a, b) refers to the inverse-gamma distribution with parameters a and b. The stick-breaking representation of the DP given in (16.6) allows us to rewrite (16.7) as the following countably infinite mixture of normals
The model specification is completed by assuming the following independent hyper-priors
where G(a, b) refers to the gamma distribution with parameters a and b.
Posterior inference can be conducted using two different kinds of Markov chain Monte Carlo (MCMC) strategies: (i) to employ a truncation of the stick-breaking representation (Ishwaran and James 2001) or (ii) to use a marginal Gibbs sampling where the mixing distributions are integrated out from the model (MacEachern and Müller 1998; Neal 2000) . Finally, we can plug-in each MCMC realization of F 0 and F 1 in (16.1) and compute the corresponding realization of the ROC curve. Note that the computation of the ROC curve requires the evaluation of the quantile function of F 0 , which is done numerically. A model similar to the one described here was proposed by Erkanli et al. (2006) .
Bayesian Bootstrap
The Bayesian bootstrap (BB) estimator of the ROC curve was proposed by Gu et al. (2008) and it is a computationally simple, yet robust, estimator. We start by outlining how the BB works in the one-population setting. Let (Y 1 ,. ..,Y n ) be a random sample from an unknown distribution F and suppose that F itself is the parameter of interest. In Efron's frequentist bootstrap (Efron 1979) , estimation and inference about F are obtained by repeatedly generating bootstrap samples, where each sample is drawn with replacement from the original data. In the bth bootstrap replicate, in expression (16.8) are assigned an Dirichlet n (1, . . . , 1) distribution and thus are smoother than those from the frequentist bootstrap. It is important to stress that in the BB the data is regarded as fixed and so we do not resample from it. The BB has connections with the DP. Specifically, it can be regarded as a non-informative version of the DP, which can be obtained by letting the precision parameter tending to zero (Gasparini 1995, Theorem 2) .
The representation of the ROC curve given in (16.2) provides the rationale for the following two-step BB algorithm, which we fully describe due to its simplicity. Let us suppose, again, that (Y 01 ,...,Y 0n 0 ) and (Y 11 ,...,Y 1n 1 ) are random samples from the non-diseased and diseased populations and let B be the number of BB resamples.
Bayesian bootstrap algorithm
Step 1 (Compute the placement values based on the BB resampling) For j = 1, . . . , n 1 , compute the placement values
∼ Dirichlet n 0 (1, . . . , 1).
(continued)
Step 2 (Generate a random realization of the ROC curve) Based on (16.2), generate a random realization of ROC(p), the cumulative distribution function of (U 1 ,...,U n 1 ), where
ind.
∼ Dirichlet n 1 (1,...,1),
The BB estimate of the ROC curve, denoted as ROC BB (p), is then obtained by averaging the random realizations of the ROC curve, that is,
Similarly,
Modeling Approaches for the Covariate Case
Let {(x 01 ,Y 01 ),...,(x 0n 0 ,Y 0n 0 )} and {(x 11 ,Y 11 ),...,(x 1n 1 ,Y 1n 1 )} be regression data for the non-diseased and diseased groups, respectively, where x 0i ∈ X ⊆ IR p and x 1 j ∈ X ⊆ IR p are p-dimensional covariate vectors and Y 0i and Y 1 j are test outcomes, for i = 1, . . . , n 0 , j = 1, . . . , n 1 . It is assumed that given the covariates, the test outcomes in the diseased and non-diseased populations are independent and that
Here, we detail the approach proposed by Inácio de Carvalho et al. (2013) for the conditional ROC curve estimation problem, which extends the no covariate approach of Sect. 16.3.1. Specifically, these authors proposed a model for the conditional ROC curves based on the specification of a probability model for the entire collection of distributions F h = {F h (· | x) : x ∈ X }, for h ∈ {0, 1}, and they further modeled the conditional distributions in each population using the following covariate-dependent mixture of normal models
The probability model for the conditional distributions is induced by specifying a prior for the collection of mixing distributions
where G hx denotes the random mixing distribution at covariate x, which is defined on IR × IR + , and G h is the prior for the collection G hX .
One possibility for modeling G h is the DDP proposed by MacEachern (2000), which is built upon the constructive definition of the DP in (16.6), where the atoms and the components of the weights are realizations of a stochastic process over X , and the weights arise from a stick-breaking representation. Justified by results in Barrientos et al. (2012) , on the full support of MacEachern's DDPs, Inácio de Carvalho et al. (2013) considered the 'single weights' DDP (De Iorio et al. 2004 , 2009 De la Cruz et al. 2007; Jara et al. 2010) , where only the atoms are indexed by the covariates, thus resulting in the following specification for the conditional random mixing distribution
where the weights {ω hk } match those from a standard DP and the atoms are given by θ hk (x) = (m hk (x), σ 2 hk ), where {m hk (x) : x ∈ X } are iid. Gaussian processes which are independent across h.
Although such formulation leads to a very flexible prior, it implies sampling realizations of the Gaussian processes at each distinct value of the covariate and, thus, inferences could take prohibitively long. This motivated Inácio de Carvalho et al. (2013) to elaborate on a linear DDP (LDDP) prior formulation (De Iorio et al. 2004 , 2009 Jara et al. 2010) , where the Gaussian processes are replaced by sufficiently rich linear (in the coefficients) functions, m hk (x) = z β hk . Here z is a q-dimensional design vector possibly including nonlinear transformations of the original covariates x. To this end, the authors considered an additive formulation based on B-splines (Eilers and Marx 1996) , referred to as B-splines DDP,
where ψ n (x, d) corresponds to the nth B-spline basis function of degree d evaluated at x, and β hk = (β hk0 , . . . , β hkpK p ). This formulation allows for the inclusion of discrete and continuous predictors.
Thus, under the LDDP formulation, the base stochastic processes are replaced with a group-specific distribution G 0h that generates the component specific regression coefficients and variances. Therefore, the B-splines DDP mixture model can be equivalently formulated as a DPM of Gaussian regression models
For each group, normal-inverse-gamma distributions were used for the parametric centering distribution,
The model specification is completed by specifying the following hyper-priors
With regard to posterior inference, the computational strategies for Dirichlet process mixture models referred in Sect. 16.3.1 apply here in the covariate setup directly. Finally, after obtaining MCMC samples for each of the parameters, we can plug-in, for each covariate x, each MCMC realization of F 0 (· | x) and F 1 (· | x) in (16.4) and compute the corresponding realization of the conditional ROC curve. The model previously described is implemented in the function LDDProc of the R library DPpackage (Jara et al. 2011) .
Illustration
The accuracy of a soluble isoform of epidermal growth factor receptor (sEGFR), present in blood, as a diagnostic test for lung cancer in women is investigated. How this accuracy may vary with age is also subject of interest. The data were collected from a case-control study conducted at the Mayo clinic in Minnesota between 1998 and 2003. The dataset includes information for 140 non-diseased women and 101 lung cancer cases. This dataset was previously analyzed by Branscum et al. (2013) . Figure 16 .2 shows the histogram of the − log(sEGFR) in both populations. The minus sign is due to the fact that the values of sEGFR tend to be lower for lung cancer cases than for controls, and so with the minus sign the usual convention that diseased individuals tend to have larger test outcomes than the non-diseased ones applies. As it can be observed, normality does not seem to apply, especially for the non-diseased population, where a bimodality is easily noticed. Figure 16 .2 also displays the estimated densities, in each group of women, under the DPM of normals model, and we can see that the model captures well the bimodality in the non-diseased group, as well as, a certain skewness in the diseased group. The hyperpriors of the DPM of normals model were set to a h = 5, b h = 1, τ h1 = 2, τ sh1 = 2, τ sh2 = 10, μ mh = 0, S mh = 100, ν h = 5, and Ψ h = 1, for h ∈ {0, 1}, while the BB estimates were obtained using 5000 resamples. With respect to the estimation of the CDFs, which are displayed in Fig. 16 .3 [Panels (a) to (f)], it can be observed that the estimates provided by the DPM of normals and the BB are almost indistinguishable. When superimposing these fits (DPM and BB) with the one obtained by the binormal model, a discrepancy can be seen, especially in the non-diseased group. The resulting ROC curves, also presented in Fig. 16 We now examine the age effect on the accuracy of the sEGFR. The B-splines dependent DPM of normals model was fit by assuming K 1 = 3, a h = 5, b h = 1, τ h1 = 2, τ sh1 = 2, τ sh2 = 10, m h = (0, 0, 0, 0), S h = 100 × I 4 , ν h = 5, and Ψ Ψ Ψ h = I 4 , for h ∈ {0, 1}. Figure 16 .4 shows the posterior means for the conditional mean functions, along with point-wise 95 % credible bands for − log(sEGFR) levels. These estimates are overlaid on the top of the raw data. This figure suggests that the − log(sEGFR) levels are more concentrated in the non-diseased than in the diseased women, across age and, further, a slightly nonlinear behavior of the conditional mean function of both groups can be observed. Figure 16 .5 presents the estimated posterior means, along with 95 % point-wise credible bands, of the conditional distribution functions in the two groups of women at three selected ages (40, 55, and 70 years old), and a change across age is clearly seen. Obviously, the same is visible in terms of the corresponding estimated ROC curves. To examine the age effect further, Fig. 16 .6 shows the estimated posterior mean, as well as the 95 % point-wise credible band, of the AUC as a function of age. This figure suggests a decrease in AUC until an age around 60 years old, and then a slight increase.
Concluding Remarks
ROC curves are a valuable tool for assessing the discriminatory power of continuous diagnostic tests. We have described and illustrated BNP approaches for ROC curve estimation and regression. Specifically, we have discussed DPM models and the BB for ROC curve estimation and an extension for the regression case based on DDP mixture models. A nice feature of the latter model is that the complete distribution of the test outcomes is allowed to smoothly change with the values of the covariates instead of just one or two characteristics (such as the mean and/or variance), as implied for most ROC regression models.
Topics of future research on BNP methods for ROC analysis include, among others, modeling diagnostic tests with mass at zero, optimal combinations of multiple tests, and time-dependent ROC curves. We end remarking that R packages for the implementation of ROC analysis tools are of great importance for practitioners. 
